Martine A Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS, sold UTHR on Jul 23, 2026
Data as of Oct 16
▼ SELL$1.2M2,279 shares at $529.86Martine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp
- Traded
- Jul 23, 2026
- Disclosed
- Jul 24, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
UTHR since disclosure
+0.9%
after the sale
Similar stocks (XLV) since disclosure
+8.7%
XLV — its sector index fund
Change in closing price from Jul 24, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$638Kdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$178Kdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1Mdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$89.8Kdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$106Kdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$1.1Mdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$130Kdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$291Kdisclosed Jul 24 · filed 1 day after the trade
- ▼ SELLMartine A Rothblatt Chairperson & CEOUTHR UNITED THERAPEUTICS Corp$203Kdisclosed Jul 24 · filed 1 day after the trade